We use cookies to improve your browsing experience and provide meaningful content. Read our cookie policy. Accept
  •  Customer Login
  • Register
  •  View Cart (0)
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us

Clontech Takara Cellartis

Close

  • ‹ Back to Transfection reagents
  • Xfect Transfection Reagent
  • Transfection tips
  • Cell lines transfected with the Xfect reagent
  • Protein transfection FAQs
  • Xfect RNA Transfection Reagent
  • Transfection reagent products
  • Protocol: transfection of cerebellar slice cultures with Xfect reagent
  • Calcium phosphate transfection of neurons
Home › Learning centers › Gene function › Transfection reagents › Xfect RNA Transfection Reagent

Gene function

  • Gene editing
    • Gene editing product finder
    • Gene editing tools and information
      • sgRNA design tools
      • Tools for successful CRISPR/Cas9 genome editing
      • Gene editing posters
      • Customer data for Guide-it products
      • How to design sgRNA sequences
      • Introduction to the CRISPR/Cas9 system
      • Gene editing of CD3+ T cells and CD34+ HSCs
    • CRISPR/Cas9 knockouts
      • Mutation detection kit comparison
      • Screening for effective guide RNAs
      • Monoallelic versus biallelic mutants
      • Indel identification kit for mutation characterization
    • CRISPR/Cas9 knockins
      • Choosing an HDR template format
      • Homology-directed repair FAQs
      • Mouse CRISPR knockin protocol
      • Site-specific gene knockins using long ssDNA
      • Efficient CRISPR/Cas9-mediated knockins in iPS cells
      • Oligo design tool for detecting precise insertions
        • Oligo design tool user guide (insertions)
    • Genome-wide screening
      • CRISPR library screening
      • CRISPR library screening webinar
      • Phenotypic screen using sgRNA library system
    • Creating and screening for SNPs
      • SNP detection with knockin screening kit
      • Oligo design tool for SNP screening
        • Oligo design tool user guide (SNPs)
      • Sign up: SNP engineering webinar
      • Guide-it SNP Screening Kit FAQs
    • CRISPR/Cas9 delivery methods
      • Electroporation-grade Cas9 for editing in diverse cell types
      • CRISPR/Cas9 gene editing with AAV
      • CRISPR/Cas9 gesicles overview
      • Cas9 Gesicles—reduced off-target effects
      • sgRNA-Cas9 delivery to many cell types
      • Tet-inducible Cas9 for gene editing
    • Cre recombinase
      • Control your Cre recombinase experiments
      • Fast Cre delivery with gesicle technology
  • Viral transduction
    • Recombinant virus comparison
    • Product finder
    • Transduction posters
    • Lentivirus
      • Lenti-X Transduction Sponge overview
        • Lenti-X Transduction Sponge tech note
        • Lenti-X Transduction Sponge compatible cell types
      • Webinars
        • Webinar: Cellular reprogramming of cancer cells for immunotherapy
        • Lentiviral particles webinar
      • Customizable SARS-CoV-2 pseudovirus
      • Lenti-X FAQs
      • Lentiviral workflow
      • Lentiviral products guide
      • Lentivirus biosafety
      • Lentiviral tips
      • Lentiviral vectors
      • Lenti-X packaging
      • High-throughput lentivirus production
      • Lenti-X Concentrator
      • Lentiviral titration
      • Lenti-X GoStix Plus video protocols
      • Lenti-X GoStix Plus FAQs
      • Rapid lentivirus titration by p24 ELISA
      • Lentiviral particles
      • Lentiviral particles—fluorescent
      • Lentiviral particles FAQs
    • Retrovirus
      • Retroviral products
      • Retro-X FAQs
      • Retro-X packaging
      • Retro-X Concentrator
    • Adeno-associated virus
      • AAV workflow
      • AAV products
      • AAV FAQs
      • AAV tech notes
        • Customer data: Purified AAV9 delivery (mouse brain)
        • Customer data: Purified AAV9 delivery (songbird brain)
        • Serotype-independent AAV vector purification
        • Customer data: Purified AAV2 delivery (mouse brain)
      • AAV videos
        • AAV2 purification video
        • AAVpro "All Serotypes" protocols
      • AAVpro Concentrator overview
    • Adenovirus
      • Adenoviral FAQs
      • Adenoviral products
      • Fastest, easiest adenoviral system ever
      • Tet-inducible adenovirus
      • Adenovirus purification kits
      • Adenovirus purification mega-scale
      • Adenovirus rapid titer
      • Adenoviral titration
  • T-cell transduction and culture
    • Technology overview
    • Adoptive T-cell therapy (ACT)
    • RetroNectin FAQs
    • Hematopoietic cell transduction
    • T-cell expansion
    • Serum-free T-cell culture
    • CultiLife culture bags protocol
    • Cytokine analysis
  • Inducible systems
    • iDimerize systems
      • Inducible protein-protein interactions—iDimerize systems
      • iDimerize systems journal club
      • iDimerize in vivo protocol
      • iDimerize systems citations
      • ARGENT cell signaling regulation kits from ARIAD
    • ProteoTuner systems
      • ProteoTuner technology overview
      • ProteoTuner citations
      • Inducible protein stabilization systems product selection guide
    • Tet-inducible systems
      • Tet systems product selection guide
      • Tet systems overview
      • Tet-One technology overview
      • Tet-On 3G plasmid system kit components
      • Tet-On 3G lentiviral system kit components
      • Tet system webinars
  • Transfection reagents
    • Xfect Transfection Reagent
    • Transfection tips
    • Cell lines transfected with the Xfect reagent
    • Protein transfection FAQs
    • Xfect RNA Transfection Reagent
    • Transfection reagent products
    • Protocol: transfection of cerebellar slice cultures with Xfect reagent
    • Calcium phosphate transfection of neurons
  • Fluorescent proteins
    • Fluorescent protein vector finder
    • Fluorescent protein excitation and emission maxima
    • Fluorescent protein antibodies selection guide
    • Fluorescent protein antibody citations
      • GFP antibody citations
      • RFP antibody citations
    • Fluorescent protein quick guide
    • Fluorescent retroviral expression vectors
    • Verify miRNA expression
    • Find EGFP vector alternatives
  • Cell biology assays
    • Technical notes
      • Cell viability and proliferation measurement
    • Citations
New products
Need help?
Contact Sales
Product Overview

Transfect all RNA types with Xfect RNA Transfection Reagent

The Xfect RNA Transfection Reagent is compatible with all types of RNA, including mRNA, single guide RNA (sgRNA), microRNA, and siRNA. The protocol is simple, and transfections can be carried out entirely in the presence of serum. Unlike most transfection reagents, the Xfect RNA Transfection Reagent has very low cytotoxicity. It combines with RNA to create biodegradable nanoparticles, which allow efficient mammalian cell transfection without any of the harmful side effects.

Transfection of messenger RNA with this reagent allows you to achieve rapid gene expression and avoid the risk of genomic integration that accompanies DNA transfection. Xfect RNA Transfection Reagent also efficiently delivers single guide RNAs (sgRNA) for CRISPR/Cas9-mediated gene editing.

The Xfect RNA Transfection Reagent can be used together with the Xfect Transfection Reagent to cotransfect mammalian cells with both DNA and RNA.

siRNA Transfection mRNA Transfection miRNA Transfection sgRNA Transfection Summary

siRNA Transfection  

Why use the Xfect RNA Transfection Reagent to transfect siRNA oligos?

  • It's effective—get better knockdown than with the leading competitor
  • It's easy—no optimization necessary
  • It's nontoxic—Xfect won't kill your cells

Effective gene silencing using transfected siRNA oligos

Having good siRNA oligos is not enough if you can't deliver those siRNAs effectively since your experiment will fail. The Xfect RNA Transfection Reagent was developed to maintain a very low cytotoxicity profile while delivering high rates of gene silencing. The ratio of oligo to reagent is pre-optimized, so you don't have to waste time on preliminary experiments. Transfecting siRNA with Xfect RNA Transfection Reagent has been shown to result in successful knockdown, e.g., a 95% decrease in luciferase activity (Figure 1).

Successful knockdown in primary cells and cell lines treated with siRNA

Figure 1. Successful knockdown in primary cells and cell lines treated with siRNA. HeLa cells (2.0 x 105), Human Dermal Fibroblasts (NHDF) cells (6.0 x 104), and Mesenchymal Stem Cells (MSCs) (5.0 x 104) were plated in 12-well plates and transfected with 50 pmol of siRNA against luciferase using Xfect RNA Transfection Reagent. All three cell types were also transfected with 1 µg of pCMV-Luc using the Xfect Transfection Reagent. Luciferase assays were performed 48 hours post-transfection. For control samples, cells were transfected with pCMV-Luc but without the siRNA. We observed a dramatic (>95%) decrease in luciferase activity in all the cells treated with siRNA.

mRNA Transfection  

Rapid gene expression using transfected mRNA

Transfection with messenger RNA using the Xfect RNA Transfection Reagent allows for rapid gene expression (within 20–24 hr after transfection), without the risk of genomic integration that comes from transfection with DNA. This is demonstrated quantitatively (Figure 2) and visually (Figure 3) for GFP mRNA, and quantitatively (Figure 4) for firefly luciferase mRNA.

Expression of GFP from primary cells and cell lines transfected with mRNA

Figure 2. Expression of green fluorescent protein (GFP) from transfection with mRNA into primary cells and cell lines. HeLa cells (2.0 x 105), HEK 293 cells (1.5 x 105), Human Dermal Fibroblasts (NHDF) cells (6.0 x 104), Mesenchymal Stem Cells (MSCs) (5.0 x 104), Jurkat Cells (3.0 x 105), and KBM7 cells (3.0 x 105) were plated in 12-well plates and transfected with 1 µg of mRNA encoding GFP with 5 µl of Xfect RNA Transfection Reagent. 20 hours later, cells were analyzed by flow cytometry and the % GFP-positive cells and the Mean Fluorescence Intensity (MFI) were determined.

 

Figure 3. GFP is expressed in HeLa cells, NHDF cells, and MSCs. HeLa cells (2.0 x 105), Human Dermal Fibroblasts (NHDF) cells (6.0 x 104), and Mesenchymal Stem Cells (MSCs) (5.0 x 104) were plated in 12-well plates and treated with 1 µg of mRNA encoding GFP with 5 µl of Xfect RNA Transfection Reagent. 20 hours later, cells were imaged using an epifluorescent microscope. Images of HeLa cells were taken at 20X magnification. Pictures of NHDF cells and MSCs were taken at 40X.

 

Xfect MicroRNA Transfection Reagent successfully transfects firefly luciferase (Fluc) messenger RNA into HeLa cells.

Figure 4. Xfect RNA Transfection Reagent successfully transfects firefly luciferase (Fluc) messenger RNA into HeLa cells. Fluc messenger RNA (0.5 μg and 1.0 μg) was transfected into HeLa cells using Xfect RNA Transfection Polymer according to the protocol described above. 24 hours after transfection, luciferase activity (Relative Light Units; RLU) was measured using a luciferase assay.

miRNA Transfection  

Efficient microRNA transfection

Xfect RNA Transfection Reagent provides high levels of transfection efficiency and cell viability for six different popular cell lines (Figure 5).

 

Efficient transfection of microRNA into 6 mammalian cell lines.

Figure 5. Efficient transfection of microRNA using the Xfect RNA Transfection Reagent. A FAM-labeled microRNA mimic was transfected into six popular cell lines using the Xfect RNA Transfection Reagent according to the protocol. 24 hr post-transfection, cells were harvested, and transfection efficiency was determined by flow cytometry. Cell viability was also measured using Trypan Blue staining. Data represents the average of three independent transfections for each cell line.

sgRNA Transfection  

Efficient Delivery of sgRNAs

Xfect RNA Transfection Reagent can efficiently deliver single guide RNAs (sgRNAs) for CRISPR/Cas9-mediated gene editing. sgRNA transfection using this reagent resulted in a functional knockout of the endogenous CD81 gene (Figure 6) and a robust (>95%) knockout of the luciferase gene (Figure 7).

Functional knockout of the endogenous CD81 gene by sgRNA transfection

Figure 6. Functional knockout of the endogenous CD81 gene by sgRNA transfection. Panel A. sgRNA targeting the 5' end of the antisense strand of CD81 was synthesized using the Guide-it sgRNA In Vitro Transcription Kit. Panel B. An HT1080 cell line (2.0 x 105 cells) stably expressing Cas9 (HT1080-Cas9) was transfected with 50 pmol of sgRNA targeting CD81, either once or twice (lower graph), using the Xfect RNA Transfection Reagent. Seven days later, cells were immunostained with a CD81 antibody (Ab) conjugated to an FITC fluorophore and analyzed by flow cytometry. The percentage of cells that did not bind CD81 was calculated. A control sample, comprised of HT1080-Cas9 cells, was analyzed by flow cytometry, either without (top, left graph) or with (top, right graph) the CD81 antibody. Both single and double transfection with sgRNA resulted in a substantial increase in cells that did not bind CD81, indicating successful CRISPR/Cas9-mediated knockout of CD81.

  

Knockout of the luciferase gene by sgRNA transfection

Figure 7. Knockout of the luciferase gene by sgRNA transfection. Panel A. Two sgRNAs (sgRNA-A and sgRNA-B) targeting sense and antisense strands of luciferase were synthesized using the Guide-it sgRNA In Vitro Transcription Kit. Panel B. 3.0 x 105 HT1080 cells stably expressing Cas9 (HT1080-Cas9) were plated in 12-well plates and transfected with 1 µg of pCMV-Luc (using the Xfect Transfection Reagent) and 200 ng of either sgRNA-A, sgRNA-B, or 100 ng each of both sgRNAs (using the Xfect RNA Transfection Reagent). 48 hours post-transfection, luciferase assays were performed. Robust knockout (>95%) of luciferase activity was observed with each sgRNA individually and in combination with each other.

Summary  

Xfect RNA Transfection Reagent has been shown to be effective for transfecting all types of RNA, including siRNA, mRNA, microRNA, and sgRNA. Using this reagent with primary cells and cell lines resulted in successful knockdown when transfecting siRNA oligos, and allowed for rapid gene expression when transfecting mRNA. Xfect RNA Transfection Reagent also provided efficient microRNA transfection and enabled effective gene knockouts when it was used to deliver sgRNAs for CRISPR/Cas9-mediated gene editing. The high transfection efficiency, low cytotoxicity, and versatility of this reagent make it a powerful tool for RNA transfection.

Related Products

Cat. # Product Size Price License Quantity Details
631450 Xfect™ RNA Transfection Reagent 1.2 mL USD $303.00

License Statement

ID Number  
91 This product is intended for in vitro research purposes only. It may not be used for (i) any human or veterinary use, including without limitation therapeutic and prophylactic use, (ii) any clinical use, including without limitation diagnostic and prognostic use, (iii) screening of chemical and/or biological compounds for the identification of pharmaceutically active agents (including but not limited to screening of small molecules), target validation, preclinical testing services, or drug development or (iv) any commercial purposes, including without limitation the performance of contract research or provision of services to a third party and the manufacture of products for general sale. Any use of this product for any of the abovementioned purposes requires a license from the Massachusetts Institute of Technology.

Xfect RNA Transfection Reagent is a complete system for highly efficient transfection of mammalian cells with all types of RNA, including messenger RNA (mRNA), small interfering RNA (siRNA), and single guide RNA (sgRNA).The protocol is simple, and transfections can be carried out entirely in the presence of serum. Xfect RNA Transfection Reagent creates biodegradable nanoparticles when combined with RNA, resulting in very low cytotoxicity.

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Efficient transfection of microRNA using the Xfect RNA Transfection Reagent

Efficient transfection of microRNA using the Xfect RNA Transfection Reagent
Efficient transfection of microRNA using the Xfect RNA Transfection Reagent. A FAM-labeled microRNA mimic was transfected into six popular cell lines using the the Xfect RNA Transfection Reagent according to the protocol. 24 hr post transfection, cells were harvested and transfection efficiency was determined by flow cytometry. Cell viability was also measured using Trypan Blue staining. Data represents the average of three independent transfections for each cell line.

Back

Successful knockdown in primary cells and cell lines treated with siRNA

Successful knockdown in primary cells and cell lines treated with siRNA

Successful knockdown in primary cells and cell lines treated with siRNA. HeLa cells (2.0 x 105), human dermal fibroblasts (NHDF) cells (6.0 x 104), and mesenchymal stem cells (MSCs) (5.0 x 104) were plated in 12-well plates and transfected with 50 pmol of siRNA against luciferase using Xfect RNA Transfection Reagent. All three cell types were also transfected with 1 µg of pCMV-Luc using the Xfect Transfection Reagent. Luciferase assays were performed 48 hours post-transfection. For control samples, cells were transfected with pCMV-Luc but without the siRNA. We observed a dramatic (>95%) decrease in luciferase activity in all the cells treated with siRNA.

Back

Expression of green fluorescent protein (GFP) from transfection with mRNA into primary cells and cell lines

Expression of green fluorescent protein (GFP) from transfection with mRNA into primary cells and cell lines

Expression of green fluorescent protein (GFP) from transfection with mRNA into primary cells and cell lines. HeLa cells (2.0 x 105), HEK 293 cells (1.5 x 105), human dermal fibroblasts (NHDF) cells (6.0 x 104), mesenchymal stem cells (MSCs) (5.0 x 104), Jurkat cells (3.0 x 105), and KBM7 cells (3.0 x 105) were plated in 12-well plates and transfected with 1 µg of mRNA encoding GFP with 5 µl of Xfect RNA Transfection Reagent. 20 hours later, cells were analyzed by flow cytometry and the % GFP-positive cells and the mean fluorescence intensity (MFI) were determined.

Back

GFP is expressed in HeLa cells, NHDF cells, and MSCs

GFP is expressed in HeLa cells, NHDF cells, and MSCs

GFP is expressed in HeLa cells, NHDF cells, and MSCs. HeLa cells (2.0 x 105), human dermal fibroblasts (NHDF) cells (6.0 x 104), and mesenchymal stem cells (MSCs) (5.0 x 104) were plated in 12-well plates and treated with 1 µg of mRNA encoding GFP with 5 µl of Xfect RNA Transfection Reagent. 20 hours later, cells were imaged using an epifluorescent microscope. Images of HeLa cells were taken at 20X magnification. Pictures of NHDF cells and MSCs were taken at 40X.

Back

Functional knockout of the endogenous CD81 gene by sgRNA transfection

Functional knockout of the endogenous CD81 gene by sgRNA transfection

Functional knockout of the endogenous CD81 gene by sgRNA transfection. Panel A. sgRNA targeting the 5’ end of the antisense strand of CD81 was synthesized using the Guide-it sgRNA In Vitro Transcription Kit. Panel B. An HT1080 cell line (2.0 x 105 cells) stably expressing Cas9 (HT1080-Cas9) was transfected with 50 pmol of sgRNA targeting CD81, either once or twice (lower graph), using the Xfect RNA Transfection Reagent. Seven days later, cells were immunostained with a CD81 antibody (Ab) conjugated to a FITC fluorophore and analyzed by flow cytometry. The percentage of cells that did not bind CD81 was calculated. A control sample, comprised of HT1080-Cas9 cells, was analyzed by flow cytometry, either without (top, left graph) or with (top, right graph) the CD81 antibody. Both single and double transfection with sgRNA resulted in a substantial increase in cells that did not bind CD81, indicating successful CRISPR/Cas9-mediated knockout of CD81.

Back

Knockout of the luciferase gene by sgRNA transfection

Knockout of the luciferase gene by sgRNA transfection

Knockout of the luciferase gene by sgRNA transfection. Panel A. Two sgRNAs (sgRNA-A and sgRNA-B) targeting sense and antisense strands of luciferase were synthesized using the Guide-it sgRNA In Vitro Transcription Kit. Panel B. 3.0 x 105 HT1080 cells stably expressing Cas9 (HT1080-Cas9) were plated in 12-well plates and transfected with 1 µg of pCMV-Luc (using the Xfect Transfection Reagent) and 200 ng of either sgRNA-A, or sgRNA-B, or 100 ng each of both sgRNAs (using the Xfect RNA Transfection Reagent). 48 hours post-transfection, luciferase assays were performed. Robust knockout (>95%) of luciferase activity was observed with each sgRNA individually and in combination with each other.

Back

The CRISPR/Cas9 system, a simple, RNA-programmable method to mediate genome editing in mammalian cells

The CRISPR/Cas9 system, a simple, RNA-programmable method to mediate genome editing in mammalian cells

The CRISPR/Cas9 system, a simple, RNA-programmable method to mediate genome editing in mammalian cells. The CRISPR/Cas9 system relies on a single guide RNA (sgRNA) directing the Cas9 endonuclease to induce a double strand break at a specific target sequence three base-pairs upstream of a PAM sequence in genomic DNA. This DNA cleavage can be repaired in one of two ways: 1) nonhomologous end joining, (NHEJ) resulting in gene knockout due to error-prone repair (orange), or 2) homology-directed repair (HDR), resulting in gene knockin due to the presence of a homologous repair template (purple).

Back

Xfect MicroRNA Transfection Reagent successfully transfects firefly luciferase (Fluc) messenger RNA into HeLa cells

Xfect MicroRNA Transfection Reagent successfully transfects firefly luciferase (Fluc) messenger RNA into HeLa cells
Xfect MicroRNA Transfection Reagent successfully transfects firefly luciferase (Fluc) messenger RNA into HeLa cells. Fluc messenger RNA (0.5 μg and 1.0 μg) was transfected into HeLa cells using Xfect MicroRNA Transfection Polymer according to the protocol described above. 24 hours after transfection, luciferase activity (Relative Light Units; RLU) was measured using a luciferase assay.

Back

631450: Xfect RNA Transfection Reagent

631450: Xfect RNA Transfection Reagent

Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2025 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.

Takara Bio

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Support
  • Contact us
  • Technical support
  • Customer service
  • Shipping & delivery
  • Sales
  • Feedback
Products
  • New products
  • Special offers
  • Instrument & reagent services
Learning centers
  • NGS
  • Gene function
  • Stem cell research
  • Protein research
  • PCR
  • Cloning
  • Nucleic acid purification
About
  • Our brands
  • Careers
  • Events
  • Blog
  • Need help?
  • Announcements
  • Quality and compliance
  • That's Good Science!
Facebook Twitter  LinkedIn

logo strip white

©2025 Takara Bio Inc. All Rights Reserved.

Region - North America Privacy Policy Terms and Conditions Terms of Use

Top



  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISAs
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • New products
  • Special offers
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing services
  • Services
  • Facilities
  • Our process
  • Resources
  • Customer service
  • Sales
  • Make an appointment with your sales rep
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • GoStix Plus FAQs
  • Partnering & Licensing
  • Vector information
  • Vector document overview
  • Vector document finder
Takara Bio's award-winning GMP-compliant manufacturing facility in Kusatsu, Shiga, Japan.

Partner with Takara Bio!

Takara Bio is proud to offer GMP-grade manufacturing capabilities at our award-winning facility in Kusatsu, Shiga, Japan.

  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Spatial biology
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • Antibodies and ELISA
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
Create a web account with us

Log in to enjoy additional benefits

Want to save this information?

An account with takarabio.com entitles you to extra features such as:

•  Creating and saving shopping carts
•  Keeping a list of your products of interest
•  Saving all of your favorite pages on the site*
•  Accessing restricted content

*Save favorites by clicking the star () in the top right corner of each page while you're logged in.

Create an account to get started

  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Our brands
  • Our history
  • In the news
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • Trademarks
  • License statements
  • Quality statement
  • HQ-grade reagents
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
  • Website FAQs

That's GOOD Science!

What does it take to generate good science? Careful planning, dedicated researchers, and the right tools. At Takara Bio, we thoughtfully develop exceptional products to tackle your most challenging research problems, and have an expert team of technical support professionals to help you along the way, all at superior value.

Explore what makes good science possible

 Customer Login
 View Cart (0)
Takara Bio
  • Home
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Clontech, TaKaRa, cellartis

  • Products
  • COVID-19 research
  • Next-generation sequencing
  • Real-time PCR
  • Stem cell research
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Nucleic acid purification
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • New products
  • Special offers
  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISA
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • Services & Support
  • OEM
  • Instrument services
  • Gene and cell therapy manufacturing
  • Customer service
  • Sales
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • Partnering & Licensing
  • Vector information
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing
  • Services
  • Facilities
  • Our process
  • Resources
  • Sales
  • Make an appointment with your sales rep
  • Online tools
  • GoStix Plus FAQs
  • Vector information
  • Vector document overview
  • Vector document finder
  • Learning centers
  • Automation systems
  • Next-generation sequencing
  • Spatial biology
  • Real-time PCR
  • Nucleic acid purification
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Stem cell research
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • APPLICATIONS
  • Molecular diagnostics
  • mRNA and protein therapeutics
  • Pathogen detection
  • Immunotherapy research
  • Cancer research
  • Alzheimer's disease research
  • Reproductive health technologies
  • Infectious diseases
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
  • About
  • BioView blog
  • That's Good Science!
  • Our brands
  • Our history
  • In the news
  • Events
  • Careers
  • Trademarks
  • License statements
  • Quality and compliance
  • HQ-grade reagents
  • International Contacts by Region
  • Need help?
  • Website FAQs
  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us